Study directory

Mental health studies with practical context.

Compare studies and check their requirements with the research team.

Back to overview

10612studies shown

Showing 6,601-6,612 of 10,612

Drug study icon

CompletedNCT00132314

Long-Acting Injectable Risperidone in the Treatment of Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In United States

SchizophreniaDrugOver 18 Years

Countries: United States
Sponsor: US Department of Veterans Affairs
Condition: Schizophrenia

Behavioral study icon

CompletedNCT02867124

Long-acting Naltrexone for Pre-release Prisoners

This summary needs review. Please check the official study record and contact the research team for details.

In United States

AddictionBehavioralOver 18 Years

Countries: United States
Sponsor: Friends Research Institute, Inc.
Condition: Addiction

Drug study icon

CompletedNCT00257725

Long-Duration Stimulant Treatment Study of ADHD in Young Children

This summary needs review. Please check the official study record and contact the research team for details.

In United States

ADHDDrugFrom 4 Years to 5 Years

Countries: United States
Sponsor: New York State Psychiatric Institute
Condition: ADHD

Behavioral study icon

WithdrawnNCT06733558

Long-term Potentiation Disruption Underlying Cognitive Impairment in ECT

This summary needs review. Please check the official study record and contact the research team for details.

In United States

Depression, BipolarityBehavioralFrom 18 Years to 80 Years

Countries: United States
Sponsor: University of New Mexico
Condition: Depression, Bipolarity

Other study type icon

CompletedNCT04788004

Long-term Recovery: Longitudinal Study of Neuro-behavioral Markers of Recovery and Precipitants of Relapse

This summary needs review. Please check the official study record and contact the research team for details.

In United States

AddictionObservationalOver 18 Years

Countries: United States
Sponsor: Virginia Polytechnic Institute and State University
Condition: Addiction

Drug study icon

TerminatedNCT01834638

Long-term Safety and Efficacy of ABT-126 in Subjects With Schizophrenia: An Extension Study for Subjects Completing Study M10-855 (NCT01655680)

This study was terminated in the United States, in the United Kingdom, and in Russia. It focuses on schizophrenia.

In United States

SchizophreniaDrugFrom 20 Years to 66 Years

Countries: United States, United Kingdom, Russia
Sponsor: AbbVie
Condition: Schizophrenia

Drug study icon

CompletedNCT01059539

Long-term Safety and Tolerability of Cariprazine for Bipolarity type I

This summary needs review. Please check the official study record and contact the research team for details.

In United States

BipolarityDrugFrom 18 Years to 65 Years

Countries: United States, Hungary, Poland, ...
Sponsor: Forest Laboratories
Condition: Bipolarity

Drug study icon

Enrolling By InvitationNCT04987229

Long-term Safety Extension Study of OLZ/SAM in Pediatric Subjects

This summary needs review. Please check the official study record and contact the research team for details.

In United States

Schizophrenia, BipolarityDrugFrom 10 Years to 17 Years

Countries: United States, Argentina, Brazil, ...
Sponsor: Alkermes, Inc.
Condition: Schizophrenia, Bipolarity

Drug study icon

CompletedNCT01395992

Long-Term Safety Extension study of Asenapine in Bipolarity type I Participants Who Completed Protocol P05691 (P05692)

This summary needs review. Please check the official study record and contact the research team for details.

In United States

BipolarityDrugOver 18 Years

Countries: United States
Sponsor: Forest Laboratories
Condition: Bipolarity

Drug study icon

CompletedNCT01617200

Long-Term Safety Extension study of Asenapine in Schizophrenia Participants Who Completed Protocol P05688 (P05689)

This summary needs review. Please check the official study record and contact the research team for details.

In United States

SchizophreniaDrugOver 18 Years

Countries: United States
Sponsor: Forest Laboratories
Condition: Schizophrenia

Drug study icon

CompletedNCT02168127

Long-Term Safety of PRC-063 in Adolescents and Adults With ADHD

This summary needs review. Please check the official study record and contact the research team for details.

In United States

ADHDDrugOver 12 Years

Countries: United States, Canada
Sponsor: Rhodes Pharmaceuticals, L.P.
Condition: ADHD

Drug study icon

TerminatedNCT01760993

Long-term Safety of SPD489 When Added to Stable Doses of Antipsychotic Medications in Clinically Stable Adults With Negative Symptoms of Schizophrenia

This study was terminated in the United States. It focuses on schizophrenia.

In United States

SchizophreniaDrugFrom 18 Years to 65 Years

Countries: United States
Sponsor: Shire
Condition: Schizophrenia

Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.